European Partnership on Rare Diseases (ERDERA) (Phase 2)
EU — Italia · scadenza 15/09/2026
European Partnership on Rare Diseases (ERDERA) (Phase 2)
Scadenza: 15/09/2026
Fonte: eu_funding_tenders
Tipo: EU
Pagina ufficiale: Apri la scheda sulla fonte ufficiale
Scheda (fonte ufficiale)
Topic metadata
- EU Programme: Horizon Europe (ID 43108390)
- Call identifier: HORIZON-HLTH-2026-02
- Call name: Partnerships in Health (2026/1)
- Type: Topic
- Opening date: 10/02/2026
- Next deadline: 15/09/2026
- Keywords: HORIZON-HLTH-2026-02-DISEASE-12, HORIZON-HLTH-2026-02, Anticancer therapy, Biobanks, Biomarkers, Cancer and its biological basis, Cardiac and Cardiovascular systems, Child health
Topic description
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- The EU is reinforced as an internationally recognised driver of research and innovation in Rare Diseases (RD)
Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.
Iscriviti oraHai già un account? Accedi